WHO announces a planned hepatitis B birth dose vaccine trial in Guinea-Bissau to improve infant protection against the virus.
← News
Disease Elimination Disease Elimination Health
Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau
Hepatitis B Birth Dose Vaccination Intervention focus
Guinea-Bissau Trial location
Prevent Mother-To-Child Transmission Public health goal